Generex Biotechnology Corporation (GNBT)

Recent filings

Generex Biotechnology Provides Update on Pending Dividend - Dec. 9, 2019

Generex Biotechnology Announces Funding Update - Dec. 5, 2019

Creek Mountain Partners, Inc. just provided an update on share ownership of Generex Biotechnology Corporation - Nov. 29, 2019

Generex Biotechnology Announces Postponement of Pending 1:1 Dividend - Nov. 27, 2019

Reminder: Generex Investor Conference Call Friday, November 29, 2019 - Nov. 27, 2019

Entry into a Material Definitive - Nov. 27, 2019

Generex Biotechnology Issues Shareholder Alert - Nov. 26, 2019

Generex Biotechnology Signs Stock Purchase Agreement to Acquire 51% of ALTuCELL, Inc. - Nov. 25, 2019

Generex Biotechnology Announces Investor Conference Call Scheduled for Friday November 29, 2019 at 9:30 AM - Nov. 13, 2019

Generex Biotechnology Corporation Just Filed Its Annual Report: Net Income (Loss) pe... - Nov. 12, 2019

Generex Biotechnology Provides Guidance: Form 10k Annual Report will be filed Tuesday Morning November 12th 2019 - Nov. 8, 2019

Generex Biotechnology Announces First-in-Human Clinical Trial of the ALTuCELL Cellular Therapy Product Altsulin® (Microencapsulated Sertoli Cells) - Nov. 5, 2019

Submission of matters to a vote of Security - Oct. 29, 2019

Generex Biotechnology: 1 Stock Dividend - Oct. 29, 2019

Generex Biotechnology: 1 Stock Dividend - Oct. 29, 2019

Generex Biotechnology Announces Extension to the Pay Date for the Previously Declared 1:1 Stock Dividend - Oct. 29, 2019

Current report, item 8.01 - Oct. 29, 2019

Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 - Oct. 29, 2019

Reminder: Generex Investor Conference Call Tomorrow October 29, 2019 - Oct. 28, 2019

Generex Announces Results of Annual Stockholders’ Meeting - Oct. 25, 2019

Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 29, 2019 at 9:30 AM - Oct. 25, 2019

Generex Biotechnology Chief Medical & Scientific Officer Dr. Jason Terrell, MD is Awarded the 2019 Shepperd Pathfinder Award from the John Ben Shepperd Public Leadership Institute - Oct. 18, 2019

Generex Biotechnology Announces Merger with Public Vehicle for Public Trading of NuGenerex Immuno-Oncology - Oct. 15, 2019

Reminder: Generex Investor Conference Call Tomorrow October 15, 2019 - Oct. 14, 2019

Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 15, 2019 at 9:30 AM - Oct. 1, 2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe - Oct. 1, 2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Signs National Sales & Distribution Agreement With AvKare Medical to Distribute Excellagen® Throughout the VA Hospital System - Sept. 30, 2019

Generex Biotechnology Announces Plans to Establish the NuGenerex Diabetes Research Center in Collaboration With Arizona Endocrinology Group & Paradise Valley Medical Family Medicine - Sept. 27, 2019

Generex Biotechnology Corporation releases salary data. CEO sees compensation fall -50% - Sept. 24, 2019

Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete - Sept. 20, 2019

Generex Biotechnology Announces First Patient Enrolled in the Phase II Clinical Trial of AE37 in Combination with Pembrolizumab (KeytrudaÒ) for the Treatment of Triple Negative Breast Cancer - Sept. 17, 2019

Generex Announces That the Process to Retire 20,375,900 GNBT “Pool Shares” is Complete - Sept. 16, 2019

Generex Biotechnology Announces Webcast and Invites All Shareholders to See and Listen to the Corporate Presentation from the 21st Annual H.C. Wainwright Global Healthcare Investment Conference - Sept. 12, 2019

Generex Biotechnology Corporation director just declared owning 3,568 shares of Generex Biotechnology Corporation - Sept. 11, 2019

Generex Biotechnology Signs Letters of Intent to Establish NuGenerex Health MSO with Arizona Endocrinology Center & Paradise Valley Family Medicine - Sept. 10, 2019

Generex Announces Date for Annual Shareholder Meeting and Pending Retirement of 20,375,900 GNBT “Pool Shares” - Sept. 6, 2019

Generex Announces Webcast - Sept. 5, 2019

Generex Biotechnology Confirms Record Date for 1:1 Dividend - Sept. 3, 2019

Generex Biotechnology Announces Time Slot for CEO Joe Moscato to Present at H.C. Wainwright Healthcare Conference - Aug. 26, 2019

Generex Biotechnology Reiterates 1:1 Stock Dividend for Clarity in the Market and Provides Details on Capital Structure - Aug. 23, 2019

Generex Announces Acquisition of Additional 38% of Subsidiary Olaregen Therapeutix in an Up-Market Transaction with a Share Exchange of GNBT Stock at $2.50 - Aug. 19, 2019

Generex Biotechnology Announces Plans for NuGenerex Immuno-Oncology Spinout through a Targeted Acquisition of a Public Company and Planned Merger with Kiromic - Aug. 16, 2019

Generex Biotechnology Defines 1:1 Stock Dividend and Provides Details on Capital Structure - Aug. 15, 2019

Generex Biotechnology Announces Update to the Previously Declared 1:1 Stock Dividend - Aug. 12, 2019

Generex News Alert: Generex to Announce Positive Shareholder News on Monday August 12, 2019 at 8 AM Payment Details for the 1:1 GNBT Stock Dividend - Aug. 9, 2019

Generex Biotechnology Announces Interview with President & CEO Joe Moscato - Aug. 8, 2019

Generex Biotechnology Welcomes MediSource Partners to the NuGenerex Family of Companies - Aug. 1, 2019

Generex Biotechnology Introduces Pantheon Medical, the Newest Member of the NuGenerex Family of Companies - July 31, 2019

Generex Biotechnology Provides a Summary of Its Investor Conference Call Held on July 25, 2019 - July 26, 2019

Reminder: Investor Conference Call Today July 25, 2019 Management to Provide Details on Generex Up-list and 1:1 Stock Dividend - July 25, 2019

Generex Biotechnology Announces Satisfaction of Debt Obligation - July 19, 2019

Generex Biotechnology Announces Investor Conference Call Scheduled for July 25, 2019 - July 16, 2019

Entry into a Material Definitive - July 16, 2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors APMA Annual Scientific Meeting - July 15, 2019

Generex Biotechnology Announces Closing on Acquisition of MediSource Partners - July 12, 2019

Generex Biotechnology Announces Acquisition of Pantheon Medical Foot & Ankle - July 11, 2019

Generex Biotechnology Provides Fiscal Year Overview - July 10, 2019

Generex Engages Donohoe Advisory to Assist with Uplisting - July 2, 2019

Generex Announces Update on 1:1 Dividend and NASDAQ Listing - June 28, 2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Receives American Podiatry Medical Associations “Seal of Approval” for Excellagen Wound Conforming Matrix - June 26, 2019

Generex Signs Letter of Intent with Kiromic to Merge with NuGenerex Immuno-Oncology Forming a Multi-Platform Clinical Stage Immunotherapy Company - June 25, 2019

Generex Investor Conference Call Recording Now Available Online Detailing 1:1 Stock Dividend, Merger for NuGenerex Immuno-Oncology and Go Forward Plans - June 24, 2019

Generex Declares 1:1 Stock Dividend - June 20, 2019

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 16 - Subsequent... - June 19, 2019

Reminder: Investor Conference Call Friday June 21st, 2019 - June 17, 2019

Notification of inability to timely file Form 10-Q or 10-QSB - June 17, 2019

Generex Provides Update to Pending 1:1 Stock Dividend - June 7, 2019

Generex Biotechnology: Report Of Independent Auditor VENETO HOLDINGS, LLC TABLE OF CONTENTS REPORT OF INDEPENDENT AUDITOR CONSOLIDATED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2018 AND DECEMBER 31, - June 5, 2019

Change In Registrants Certifying - June 5, 2019

Generex Biotechnology CEO Joe Moscato To Present at H.C. Wainwright Healthcare Conference - June 4, 2019

Generex Biotechnology Announces Share Dividend & Strategic Plans - May 31, 2019

Generex Biotechnology Announces that its Subsidiary Olaregen Therapeutix Launches Excellagen at The Symposium on Advanced Wound Care (SAWC) in San Antonio, TX - May 16, 2019

Generex Biotechnology Announces Postponement of Its May 15th Investor Conference Call - May 15, 2019

Generex Biotechnology Corporation director just declared owning 320,345 shares of Generex Biotechnology Corporation - May 14, 2019

Generex Biotechnology Subsidiary NuGenerex Diagnostics Announces Sales for its Rapid Point-of-Care Malaria Diagnostic Test Kit - May 2, 2019

Generex Biotechnology Announces Organizational Roadmap & Investor Conference Call: Update on Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans - April 29, 2019

Generex Biotechnology Announces Organizational Roadmap & Investor Conference Call: Update on Product Launch, New Acquisitions, Financing, Expansion Initiatives & Strategic Plans - April 29, 2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors Prestigious Diabetic Limb Salvage Conference in Washington D.C. - April 18, 2019

Generex Biotechnology Corporation Just Filed Its Quarterly Report: Note 6 - Net Income ... - April 16, 2019

Kali-Extracts To Present Cannabis Treatment R&D For $170 Million In Pharmaceutical Market Opportunity On April 17th - April 9, 2019

Generex Biotechnology Corporation Appoints Mark J. Prioletti to the Board of Directors - April 8, 2019

Departure of Directors or Certain - April 5, 2019

Entry into a Material Definitive - April 4, 2019

Generex Addresses Shareholder Concern Over 8-K and Quarterly Filing - April 4, 2019

Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million - March 29, 2019

It has been discovered that the - March 28, 2019

Generex Biotechnology Partner Olaregen Therapeutix, Inc. Selected to Present a Formal Poster Session at Prestigious Diabetic Limb Salvage Meeting - March 26, 2019

Generex Biotechnology: Securities And Exchange Commission WASHINGTON, D.C. 20549 FORM 10-Q - March 25, 2019

Generex Biotechnology: Statements Of Redeemable Convertible Preferred Stock And Stockholders’ Deficit - March 25, 2019

USMJ and PURA Update Dividend Distribution Plans With PJET and NOUV To Include New Developments With WCVC and KALY - March 22, 2019

Generex Biotechnology: Report Of Independent Registered Public Accounting Firm OLAREGEN THERAPEUTIX INC - March 22, 2019

KALY Phase One Cannabis Extract COPD Research To Be Published This Friday, March 22, 2019 - March 20, 2019

KALY Initiates Phase Two Cannabis Extract COPD Treatment Study - March 18, 2019

Notification of inability to timely file Form 10-Q or 10-QSB - March 18, 2019

KALY Cannabis Patent Featured In PURA Report On Progress Toward $5 Million Sales Goal - March 8, 2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Appointment of Vice President of Business Strategy - March 8, 2019

Puration Signs New CBD Beverage Distribution Orders With Even Bigger Orders Underway Fueling M&A Interest - March 7, 2019

Generex Investor Conference Call Now Available Online - March 1, 2019

Departure of Directors or Certain - March 1, 2019

PURA - Puration Announces Analyst Update Report Coming Thursday February 28, 2019 - Feb. 26, 2019

Sorry, no schedule available for this company

No known shareholders

Generex Biotechnology Corporation (GNBT)

140

cctranscripts

yesterday

Generex Biotechnology Provides Update on Pending Dividend http://www.otcmarkets.com/stock/GNBT/news?id=248817

cctranscripts

Dec. 5, 2019

Generex Biotechnology Announces Funding Update http://www.otcmarkets.com/stock/GNBT/news?id=248553

cctranscripts

Nov. 29, 2019

Creek Mountain Partners, Inc. just provided an update on share ownership of Generex Biotechnology Corporation http://www.conferencecalltranscripts.org/pink/summary?id=7128821

cctranscripts

Nov. 27, 2019

Generex Biotechnology Announces Postponement of Pending 1:1 Dividend http://www.otcmarkets.com/stock/GNBT/news?id=247764

cctranscripts

Nov. 27, 2019

Reminder: Generex Investor Conference Call Friday, November 29, 2019 http://www.otcmarkets.com/stock/GNBT/news?id=247740

cctranscripts

Nov. 27, 2019

Entry into a Material Definitive http://www.conferencecalltranscripts.org/pink/summary?id=7114817

cctranscripts

Nov. 26, 2019

Generex Biotechnology Issues Shareholder Alert http://www.otcmarkets.com/stock/GNBT/news?id=247611

cctranscripts

Nov. 25, 2019

Generex Biotechnology Signs Stock Purchase Agreement to Acquire 51% of ALTuCELL, Inc. http://www.otcmarkets.com/stock/GNBT/news?id=247327

cctranscripts

Nov. 13, 2019

Generex Biotechnology Announces Investor Conference Call Scheduled for Friday November 29, 2019 at 9:30 AM http://www.otcmarkets.com/stock/GNBT/news?id=246130

cctranscripts

Nov. 12, 2019

Generex Biotechnology Corporation Just Filed Its Annual Report: Net Income (Loss) pe... http://www.conferencecalltranscripts.org/pink/summary?id=7041398

cctranscripts

Nov. 8, 2019

Generex Biotechnology Provides Guidance: Form 10k Annual Report will be filed Tuesday Morning November 12th 2019 http://www.otcmarkets.com/stock/GNBT/news?id=245703

cctranscripts

Nov. 5, 2019

Generex Biotechnology Announces First-in-Human Clinical Trial of the ALTuCELL Cellular Therapy Product Altsulin® (Microencapsulated Sertoli Cells) http://www.otcmarkets.com/stock/GNBT/news?id=245285

cctranscripts

Oct. 29, 2019

Submission of matters to a vote of Security http://www.conferencecalltranscripts.org/pink/summary?id=6974133

cctranscripts

Oct. 29, 2019

Generex Biotechnology: 1 Stock Dividend http://www.conferencecalltranscripts.org/pink/summary?id=6974248

cctranscripts

Oct. 29, 2019

Generex Biotechnology: 1 Stock Dividend http://www.conferencecalltranscripts.org/pink/summary?id=6974442

cctranscripts

Oct. 29, 2019

Generex Biotechnology Announces Extension to the Pay Date for the Previously Declared 1:1 Stock Dividend http://www.otcmarkets.com/stock/GNBT/news?id=244564

cctranscripts

Oct. 29, 2019

Current report, item 8.01 http://www.conferencecalltranscripts.org/pink/summary?id=6974043

cctranscripts

Oct. 29, 2019

Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 http://www.conferencecalltranscripts.org/pink/summary?id=6974098

cctranscripts

Oct. 28, 2019

Reminder: Generex Investor Conference Call Tomorrow October 29, 2019 http://www.otcmarkets.com/stock/GNBT/news?id=244428

cctranscripts

Oct. 25, 2019

Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 29, 2019 at 9:30 AM http://www.otcmarkets.com/stock/GNBT/news?id=244335
 


Feedback